Clean Yield Group’s Edwards Lifesciences EW Stock Holding History

Clean Yield Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$88.4K	Hold	1,024	–	–	0.02%	209
2026 Q2	$92.6K	Buy	1,024 +24	+2%	+$2.01K	0.02%	202
2026 Q1	$80.1K	Sell	1,000 -10	-1%	-$824	0.02%	197
2025 Q4	$86.1K	Hold	1,010	–	–	0.02%	188
2025 Q3	$78.5K	Hold	1,010	–	–	0.02%	195
2025 Q2	$79K	Hold	1,010	–	–	0.02%	194
2025 Q1	$73.2K	Hold	1,010	–	–	0.02%	199
2024 Q4	$74.8K	Buy	1,010 +986	+4,108%	+$69K	0.02%	200
2024 Q3	$1.58K	Hold	24	–	–	﹤0.01%	428
2024 Q2	$2.22K	Buy	+24	New	+$2.12K	﹤0.01%	344

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Clean Yield Group's EW Position: Q3 2026 in Review

Clean Yield Group held its Edwards Lifesciences (EW) position steady in Q3 2026 at 1,024 shares worth $88.4K. The position accounts for 0.02% of the portfolio, ranked #209.

Clean Yield Group first reported a position in EW in Q2 2024 and has held it in 10 quarters since. The position peaked at $92.6K in Q2 2026. 492 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Clean Yield Group held 1,024 shares of Edwards Lifesciences worth $88.4K as of Q3 2026.
Clean Yield Group left its Edwards Lifesciences share count unchanged in Q3 2026.
Edwards Lifesciences made up 0.02% of Clean Yield Group's portfolio in Q3 2026, its #209 holding.
Clean Yield Group first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 10 quarters since.
Clean Yield Group's Edwards Lifesciences position peaked at $92.6K in Q2 2026.
492 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Clean Yield Group's 13F filing for Q3 2026, filed 28 Oct 2026.